Cutaneous arteritis during olaparib treatment for ovarian cancer

被引：2
|
作者：
Iinuma, Shin [1 ]
Takahashi, Chiaki [1 ]
Negishi, Hideaki [2 ]
Ishida-Yamamoto, Akemi [3 ]
机构：
[1] Japanese Red Cross Kitami Hosp, Dept Dermatol, Kitami, Hokkaido, Japan
[2] Japanese Red Cross Kitami Hosp, Dept Obstet & Gynecol, Kitami, Hokkaido, Japan
[3] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan
来源：
JOURNAL OF DERMATOLOGY | 2021年 / 48卷 / 03期
关键词：
D O I：
10.1111/1346-8138.15749
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E140 / E141
页数：2
相关论文
共 50 条
  • [31] Safety evaluation of olaparib for treating ovarian cancer
    Lheureux, Stephanie
    Bowering, Valerie
    Karakasis, Katherine
    Oza, Amit M.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1305 - 1316
  • [32] Experience with the use of olaparib in patients with ovarian cancer
    Gallardo-Rincon, Dolores
    Alamilla-Garcia, Gabriela
    Montes-Servin, Edgar
    Morales-Vazquez, Flavia
    Cano-Blanco, Claudia
    Coronel-Martinez, Jaime
    Bahena-Gonzalez, Antonio
    Gerson-Cwilich, Raquel
    Isla-Ortiz, David
    Toledo-Leyva, Alfredo
    Montes-Servin, Elizabeth
    Michel-Tello, David
    Espinosa-Romero, Raquel
    GACETA MEDICA DE MEXICO, 2019, 155 (06): : 585 - 589
  • [33] Olaparib for the treatment of breast cancer
    Robert, Marie
    Frenel, Jean-Sebastien
    Gourmelon, Carole
    Patsouris, Anne
    Augereau, Paule
    Campone, Mario
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (06) : 751 - 759
  • [34] Olaparib for the treatment of breast cancer
    Griguolo, Gaia
    Dieci, Maria Vittoria
    Guarneri, Valentina
    Conte, PierFranco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (06) : 519 - 530
  • [35] EFFECT OF OLAPARIB TREATMENT ON CELL CYCLE, SENESCENCE AND CELL DEATH IN OVARIAN CANCER CELLS
    Tudrej, P.
    Glowala-Kosinska, M.
    Sojka, D.
    Cortez, A. J.
    Lisowska, K. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A91 - A91
  • [36] Olaparib Tablet: A Review in Ovarian Cancer Maintenance Therapy
    Heo, Young-A
    Dhillon, Sohita
    TARGETED ONCOLOGY, 2018, 13 (06) : 801 - 808
  • [37] Olaparib Tablet: A Review in Ovarian Cancer Maintenance Therapy
    Young-A Heo
    Sohita Dhillon
    Targeted Oncology, 2018, 13 : 801 - 808
  • [38] Olaparib, PARP1 inhibitor in ovarian cancer
    Marchetti, Claudia
    Imperiale, Ludovica
    Gasparri, Maria Luisa
    Palaia, Innocenza
    Pignata, Sandro
    Boni, Terenzio
    Bellati, Filippo
    Panici, Pierluigi Benedetti
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (10) : 1575 - 1584
  • [39] OVARIAN CANCER Olaparib maintenance moves to first line
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (12) : 725 - 725
  • [40] Olaparib: a promising PARP inhibitor in ovarian cancer therapy
    Ying Chen
    Lei Zhang
    Quan Hao
    Archives of Gynecology and Obstetrics, 2013, 288 : 367 - 374
12345